rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Herm Rosenman

Director

Company insider

Files Form 4 as: Chief Financial Officer, Natera; Director, DermTech; Director, Oxford Immunotec Global; Director, Vivus; Senior VP, Finance & CFO, Gen Probe; Director, ARYx Therapeutics; Director, Infinity Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
248
Buys
5
Sells
18
Bought
$433K
Sold
$35.8M
Companies
7
Companies where not an officer
5
First trade
11 May 2006
Last trade
26 Jun 2026
Last filed
30 Jun 2026

Companies traded

Where they are an officer
NTRA NateraDirector, Officer · Diagnostics & Labs · last 26 Jun 20260 buys · 16 sells
Gen ProbeOfficer · last 1 Aug 20120 buys · 2 sells
Everywhere else they filed: board seats, 10% stakes, other companies
DermTechDirector · last 1 Jun 20232 buys · 0 sells
Oxford Immunotec GlobalDirector · last 8 Mar 20210 buys · 0 sells
VivusDirector · last 20 Feb 20203 buys · 0 sells
ARYx TherapeuticsDirector · last 30 Apr 20100 buys · 0 sells
Infinity PharmaceuticalsDirector · last 12 Sep 20070 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
26 Jun 2026filed 30 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—1,571filing
26 Jun 2026filed 30 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—106filing
26 Jun 2026filed 30 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—1,571filing
26 Jun 2026filed 30 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—106filing
24 Jun 2026filed 26 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$4.1M16,530 at $250.00filing
24 Jun 2026filed 26 Jun 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$4.1M16,530 at $250.00filing
24 Apr 2026filed 28 Apr 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—117filing
24 Apr 2026filed 28 Apr 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—222filing
24 Apr 2026filed 28 Apr 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—117filing
24 Apr 2026filed 28 Apr 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—222filing
30 Jan 2026filed 3 Feb 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—99filing
30 Jan 2026filed 3 Feb 2026NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—99filing
12 Dec 2025filed 16 Dec 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$3.3M14,372 at $226.62filing
12 Dec 2025filed 16 Dec 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$5.0M21,910 at $227.35filing
12 Dec 2025filed 16 Dec 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$2.7M11,987 at $228.49filing
12 Dec 2025filed 16 Dec 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Sold$34K150 at $229.10filing
31 Oct 2025filed 16 Dec 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—132filing
25 Jul 2025filed 29 Jul 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—153filing
27 Jun 2025filed 1 Jul 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—2,143filing
27 Jun 2025filed 1 Jul 2025NTRA NateraDiagnostics & LabsSEC FORM 4 Code A—271filing

Sectors

Health Care16
Not placed7

Buys in green, sells in red, by the company’s sector.

Related people

Jonathan SheenaDirector and Other role · Director and Other at Natera, filing Form 4 there in the last year
Matthew RabinowitzExecutive Chairman · Executive Chairman at Natera, filing Form 4 there in the last year
Steven Leonard ChapmanCEO and President · CEO and President at Natera, filing Form 4 there in the last year
Solomon MoshkevichPresident, Clinicaldiagnostics · President, Clinicaldiagnostics at Natera, filing Form 4 there in the last year
John FeskoPresident, Chief Bus. Officer · President, Chief Bus. Officer at Natera, filing Form 4 there in the last year
Michael Burkes BrophyChief Financial Officer · Also traded NTRA in the last 90 days
Daniel RabinowitzSec. and Chief Legal Officer · Also traded NTRA in the last 90 days